Abstract
Crystal structure of the compound entitled 2-methylamino-5-[(5-methyl-2-benzoxazolinone-3-yl)methyl]-1,3,4-thiadiazole dihydrophosphate is determined using X-ray analysis and compared with the structure obtained from semiempirical and RHF methods at various levels of theory. RHF/6-31G(d) calculations offer the best conformity with X-ray results for bond lengths and bond angles. Moreover, at the result of the comparison of various combinations of basis sets and methods, it appears that there is not much gain in accuracy by using sophisticated methods.
Similar content being viewed by others
References
Song Y, Connor DT, Sercel AD, Sorenson RJ, Doubleday R, Unangst PC, Roth BD, Beylin VG, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA, Dyer RD (1999) J Med Chem 42:1161–1169
Labanauskas L, Kalcas E, Udrénaité E, Gaidelis P, Brukštus A, Daukšas V (2001) Pharmazie 56:617–619
Şahin G, Palaska E, Kelicen P, Demirdamar R, Altınok G (2001) Arzneim-Forsch Drug Res 51(6):478–484
Maliszewska-Guz A, Wujec M, Pitucha M, Dobosz M, Chodkowska A, Jagiełło-Wójtowitcz E, Mazur L, Kozioł AE (2005) Czech Chem Commun 70:51–62. doi:10.1135/cccc20050051
Foroumadi A, Asadipour A, Mirzaei M, Karimi J, Emami S (2002) Il Farmaco 57:765–769. doi:10.1016/S0014-827X(02)01277-6
Mohan J (2003) Indian J Chem 42B:401–404
Demirbaş N, Karaoğlu Ş, Demirbaş A, Sancak K (2004) Eur J Med Chem 39:793–804. doi:10.1016/j.ejmech.2004.06.007
Oruç EE, Rollas S, Kandemirli F, Shvets N, Dimoglo AS (2004) J Med Chem 47:6760–6767. doi:10.1021/jm0495632
Swamy SN, Priya BS, Prabhuswamy B, Doreswamy BH, Prasad JS, Rangappa KS (2006) Eur J Med Chem 41:531–538. doi:10.1016/j.ejmech.2005.12.009
Kalcheva V, Mincheva Z, Andreeva P (1990) Arzneim-Forsch Drug Res 40(9):1030–1034
Abdelaal SM, Kong S, Bauer L (1992) J Heterocycl Chem 29:1069–1076
Weinstock J, Gaitanopoulos DE, Stringer OD, Franz RG, Hieble JP, Kinter LB, Mann WA, Flaim KE, Gessner G (1987) J Med Chem 30:1166–1176. doi:10.1021/jm00390a009
Shankaran K, Donnelly KL, Shah SK, Humes JL, Pacholok SG, Grant SK, Green BG, MacCoss M (1997) Bioorg Med Chem Lett 7(22):2887–2892. doi:10.1016/S0960-894X(97)10101-9
Gökhan N, Erdoğan H, Durlu NT, Demirdamar R, Özalp M (2003) Arzneim-Forsch Drug Res 53(2):114–120
Gökhan N, Aktay G, Erdoğan H (2004) Turk J Chem 28:123–132
Soyer Z, Bas M, Pabuççuoğlu A, Pabuççuoğlu V (2005) Arch Pharm 338(9):405–410. doi:10.1002/ardp.200500106
Köksal M, Gökhan N, Küpeli E, Yeşilada E, Erdoğan H (2005) Arch Pharm 338:117–125. doi:10.1002/ardp.200400937
Ökçelik B, Ünlü S, Banoğlu E, Küpeli E, Yeşilada E, Şahin MF (2003) Arch Pharm 336(9):406–412. doi:10.1002/ardp.200300778
Ünlü S, Nacak Baytaş S, Küpeli E, Yeşilada E (2003) Arch Pharm 336:310–321. doi:10.1002/ardp.200300748
Salgın-Gökşen U, Gökhan-Kelekçi N, Göktaş Ö, Köysal Y, Kılıç E, Işık Ş, Aktay G, Özalp M (2007) Bioorg Med Chem 15:5738–5751. doi:10.1016/j.bmc.2007.06.006
Sheldrick GM (1997) SHELXS97. Program for the solution of crystal structure. University of Göttingen, Germany
Sheldrick GM (1997) SHELXL97. Program for the refinement of crystal structures. University of Göttingen, Germany
Hypercube Inc. (2003) HyperChem 7.5
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Comperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2003) Gaussian03. Gaussian Int, Pittsburg, PA
Farrugia LJ (1997) J Appl Cryst 30:565
Köysal Y, Işık S, Köksal M, Erdoğan H, Gökhan N (2003) Acta Cryst E59:o1975–o1976
Köysal Y, Işık S, Köksal M, Erdoğan H, Gökhan N (2004) Acta Crystallogr C60:o232–o234
Lee C, Yang W, Parr RG (1988) Phys Rev B 37:785–789. doi:10.1103/PhysRevB.37.785
Becke AD (1988) Phys Rev A 38:3098–3100. doi:10.1103/PhysRevA.38.3098
Acknowledgment
The authors acknowledge the support of Hacettepe University Research Fund (project no: 0302602001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaynak, F.B., Eriksson, L., Salgın-Gökşen, U. et al. Molecular structure of 2-methylamino-5-[(5-methyl-2-benzoxazolinone-3-yl)methyl]-1,3,4-thiadiazole dihydrophosphate: a combined X-ray crystallographic and ab initio study. Struct Chem 19, 757–764 (2008). https://doi.org/10.1007/s11224-008-9360-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-008-9360-5